Cargando…
Preclinical multi-target strategies for myocardial ischemia-reperfusion injury
Despite promising breakthroughs in diagnosing and treating acute coronary syndromes, cardiovascular disease’s high global mortality rate remains indisputable. Nearly half of these patients died of ischemic heart disease. Primary percutaneous coronary intervention (PCI) and coronary artery bypass gra...
Autores principales: | Li, Yuqing, Gao, Yi, Li, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444048/ https://www.ncbi.nlm.nih.gov/pubmed/36072870 http://dx.doi.org/10.3389/fcvm.2022.967115 |
Ejemplares similares
-
Calpain: the regulatory point of myocardial ischemia-reperfusion injury
por: Liu, Guo-Yang, et al.
Publicado: (2023) -
Cardioprotective Effects and Possible Mechanisms of Luteolin for Myocardial Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Evidence
por: Pan, Qinyuan, et al.
Publicado: (2022) -
Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
por: Fernandez Rico, Carlota, et al.
Publicado: (2022) -
Editorial: New Strategies to Inhibit Cell Death in Myocardial Ischemia-Reperfusion Injury: How to Succeed?
por: Barrère-Lemaire, Stéphanie, et al.
Publicado: (2022) -
The Protective Effect of Sevoflurane Conditionings Against Myocardial Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Trials in in-vivo Models
por: Hu, Bin, et al.
Publicado: (2022)